Wu Xian, Zhang Haiyang, Liu Hanmin
Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Division of Pediatric Pulmonology and Immunology, NHC Key Laboratory of Chronobiology, West China Second University Hospital, Sichuan University, Chengdu, China.
Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
Front Public Health. 2025 Jul 8;13:1514016. doi: 10.3389/fpubh.2025.1514016. eCollection 2025.
Earlier studies have indicated a positive correlation systemic immune-inflammatory index (SII) and systemic inflammatory response index (SIRI) levels and the development of coronary heart disease (CHD). However, the correlation between SII, SIRI levels and the incidence of CHD in patients with asthma has not been described. The purpose of the study was to research the potential correlation between the levels of SII, SIRI and the incidence of CHD in patients with asthma.
We conducted a retrospective cross-sectional analysis in which data of individuals from the National Health and Nutrition Examination Survey (NHANES) between 2011 and 2018. This study included 39,156 adults. Weighted multivariable regression analysis and subgroup analyses were used to assess the independent and combined associations between CHD prevalence and SII, SIRI levels of asthmatic population.
Totally, 2,321 adults were included in our analysis, with 116 participants experiencing CHD and the remaining 2,205 participants being free of CHD. SII levels did not significantly correlate with any of the participants' baseline characteristics, nor did SIRI levels ( < 0.1). Higher levels of SII were related to increased incidence of CHD, with an OR of 1.462 (95% CI, 1.031-1.893) ( < 0.001). Similarly, SIRI levels had similar results, with OR of 1.268 (95% CI, 1.095-1.441) ( < 0.05). Positive correlations between SII, SIRI levels and the incidence of CHD were observed ( < 0.05). Curve fitting further illustrated a positive correlation between SII, SIRI and the incidence of CHD in participants with asthma. Threshold effect analysis showed that higher levels of SII and SIRI were associated with a higher incidence of CHD, especially when SII and SIRI levels exceeded the thresholds of 411.238 and 1.812. Stratified analyses confirmed that the associations between higher SII and SIRI and increased CHD incidence in most subgroups remained consistent.
The incidence of CHD in asthmatic individuals was positively correlated with elevated SII and SIRI levels among US adults. SII and SIRI serve as recently emerged inflammatory markers for assessing CHD prevalence in the asthmatic population. However, in order to confirm these findings, more rigorous large-scale prospective studies are needed.
早期研究表明,全身免疫炎症指数(SII)和全身炎症反应指数(SIRI)水平与冠心病(CHD)的发生呈正相关。然而,SII、SIRI水平与哮喘患者冠心病发病率之间的相关性尚未见报道。本研究旨在探讨SII、SIRI水平与哮喘患者冠心病发病率之间的潜在相关性。
我们进行了一项回顾性横断面分析,纳入了2011年至2018年美国国家健康与营养检查调查(NHANES)中的个体数据。本研究共纳入39156名成年人。采用加权多变量回归分析和亚组分析来评估哮喘人群中冠心病患病率与SII、SIRI水平之间的独立关联和联合关联。
我们的分析共纳入2321名成年人,其中116名参与者患有冠心病,其余2205名参与者未患冠心病。SII水平与任何参与者的基线特征均无显著相关性,SIRI水平亦如此(P<0.1)。较高的SII水平与冠心病发病率增加相关,比值比(OR)为1.462(95%置信区间[CI],1.031 - 1.893)(P<0.001)。同样,SIRI水平也有类似结果,OR为1.268(95%CI, 1.095 - 1.441)(P<0.05)。观察到SII、SIRI水平与冠心病发病率之间存在正相关(P<0.05)。曲线拟合进一步表明,哮喘患者中SII、SIRI与冠心病发病率呈正相关。阈值效应分析表明,较高的SII和SIRI水平与较高的冠心病发病率相关,尤其是当SII和SIRI水平超过411.238和1.812的阈值时。分层分析证实,在大多数亚组中,较高的SII和SIRI与冠心病发病率增加之间的关联保持一致。
在美国成年人中,哮喘患者的冠心病发病率与升高的SII和SIRI水平呈正相关。SII和SIRI作为新出现的炎症标志物,可用于评估哮喘人群中的冠心病患病率。然而,为了证实这些发现,需要更严格的大规模前瞻性研究。